Abstract
Follenzi and colleagues show that endothelial cells can be obtained starting from blood CD34+ cells of both healthy and hemophilic donors passing through iPSC generation. During the differentiation process the cells can be genetically modified by LV to express FVIII; corrected endothelial cells secrete FVIII in vitro and ameliorate the hemophilic phenotype in a mouse model of the disease.
Original language | English |
---|---|
Pages (from-to) | 1391-1406 |
Number of pages | 16 |
Journal | Stem Cell Reports |
Volume | 11 |
Issue number | 6 |
DOIs | |
Publication status | Published - 11 Dec 2018 |
Keywords
- FVIII
- cell and gene therapy
- chimeric vasculature
- endothelial cells
- hemophilia A
- induced pluripotent stem cells (iPSCs)
- lentiviral vectors